1. Home
  2. RAIL vs ABOS Comparison

RAIL vs ABOS Comparison

Compare RAIL & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FreightCar America Inc.

RAIL

FreightCar America Inc.

N/A

Current Price

$4.69

Market Cap

141.0M

Sector

Industrials

ML Signal

N/A

Logo Acumen Pharmaceuticals Inc.

ABOS

Acumen Pharmaceuticals Inc.

N/A

Current Price

$0.18

Market Cap

165.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RAIL
ABOS
Founded
1901
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Railroads
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
141.0M
165.6M
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
RAIL
ABOS
Price
$4.69
$0.18
Analyst Decision
Strong Buy
Hold
Analyst Count
2
6
Target Price
★ $10.67
$1.00
AVG Volume (30 Days)
303.0K
★ 5.5M
Earning Date
11-09-2026
10-26-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 134.94
N/A
EPS
★ 0.32
N/A
Revenue
★ $500,991,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$48.30
N/A
P/E Ratio
$14.15
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$3.85
$0.19
52 Week High
$14.90
$3.60

Technical Indicators

Market Signals
Indicator
RAIL
ABOS
Relative Strength Index (RSI) 43.74 21.26
Support Level $3.94 N/A
Resistance Level $5.48 $2.82
Average True Range (ATR) 0.34 0.03
MACD 0.11 0.02
Stochastic Oscillator 43.64 6.47

Price Performance

Historical Comparison
RAIL
ABOS

About RAIL FreightCar America Inc.

FreightCar America Inc is a diversified manufacturer and supplier of railcars and railcar components. It designs and manufactures a variety of railcar types for transportation of bulk commodities and containerized freight products in North America. The company also provides railcar rebody and repair services, railcar conversion services, and supplies railcar parts. The company has two segments: Manufacturing and Aftermarket. The majority of the company's revenue is derived from the Manufacturing segment, which includes new railcar manufacturing, used railcar sales, and various conversions and rebodies. Geographically, it generates the maximum revenue from the United States.

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.

Share on Social Networks: